Bd announces early tender results for cash tender offers by morgan stanley & co. ll

Franklin lakes, n.j. , march 30, 2022 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company today announced the early results and pricing terms of morgan stanley & co. llc's ("morgan stanley") previously announced cash tender offers (each, an "offer" and collectively, the "offers") for the notes set forth below (collectively, the "notes" and each a "series" of notes), up to a maximum aggregate combined purchase price (including accrued and unpaid interest from the last interest payment date to, but excluding, the applicable settlement date (as defined in the offer to purchase) ("accrued interest") on such notes payable in connection with such offers) of $200,000,000.00 (the "maximum tender payment").
BDX Ratings Summary
BDX Quant Ranking